{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:07:16Z","timestamp":1792055236447,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.otc.2011.03.010","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T17:45:19Z","timestamp":1304444719000},"page":"727-739","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacotherapy for\u00a0Allergic Rhinitis"],"prefix":"10.1016","volume":"44","author":[{"given":"Thuy-Anh N.","family":"Melvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpen A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.otc.2011.03.010_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00019053-200422060-00002","article-title":"The economic burden of allergic rhinitis: a critical evaluation of the literature","volume":"22","author":"Reed","year":"2004","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.otc.2011.03.010_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1081-1206(10)61084-8","article-title":"Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence","volume":"97","author":"Santos","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.otc.2011.03.010_bib3","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1185\/030079904X13266","article-title":"Allergic rhinitis and impairment issues in school children: a consensus report","volume":"20","author":"Blaiss","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.otc.2011.03.010_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.otc.2009.11.005","article-title":"Rhinogenic laryngitis, cough, and the unified airway","volume":"43","author":"Krouse","year":"2010","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.otc.2011.03.010_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/00016480600672550","article-title":"Topical glucocorticosteroids in rhinitis","volume":"126","author":"Mygind","year":"2006","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.otc.2011.03.010_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/bmj.4.5890.464","article-title":"Local effect of intranasal beclomethasone dipropionate aerosol in hay fever","volume":"4","author":"Mygind","year":"1973","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.otc.2011.03.010_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.otc.2007.11.014","article-title":"Allergic rhinitis\u2014current pharmacotherapy","volume":"41","author":"Krouse","year":"2008","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.otc.2011.03.010_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0091-6749(82)90144-0","article-title":"Multicentric study of beclomethasone dipropionate nasal aerosol in adults with seasonal allergic rhinitis","volume":"69","author":"Siegel","year":"1982","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.otc.2011.03.010_bib9","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0091-6749(99)70073-4","article-title":"Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide","volume":"104","author":"Agertoft","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.otc.2011.03.010_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/pai.2006.19.146","article-title":"Safety of mometasone furoate nasal spray in children with allergic rhinitis as young as 2 years of age: a randomized controlled trial","volume":"19","author":"Cutler","year":"2006","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"10.1016\/j.otc.2011.03.010_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1067\/mai.2002.121703","article-title":"Early treatment of perennial rhinitis with budesonide or cetirizine and its effect on long-term outcome","volume":"109","author":"Rinne","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2011.03.010_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.otohns.2003.09.020","article-title":"Effects of three nasal topical steroids in the intraocular pressure compartment","volume":"130","author":"Bross-Soriano","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.otc.2011.03.010_bib13","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1542\/peds.105.2.e23","article-title":"Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate","volume":"105","author":"Skoner","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.otc.2011.03.010_bib14","first-page":"5","article-title":"Second generation H1-receptor antagonists","volume":"66","author":"Simons","year":"1991","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.otc.2011.03.010_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1398-9995.2006.01277.x","article-title":"Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.otc.2011.03.010_bib16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaci.2004.05.070","article-title":"XPERT Study Group. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis","volume":"114","author":"Bachert","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.otc.2011.03.010_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2500\/aap.2009.30.3296","article-title":"Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis","volume":"30","author":"Shah","year":"2009","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.otc.2011.03.010_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2500\/aap.2010.31.3317","article-title":"Comprehensive review of olopatadine: the molecule and its clinical entities","volume":"31","author":"Kaliner","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"9","key":"10.1016\/j.otc.2011.03.010_bib19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1517\/14656566.2010.485609","article-title":"Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older","volume":"11","author":"Roland","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.otc.2011.03.010_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/eci.09.89","article-title":"Olopatadine nasal spray for the treatment of allergic rhinitis","volume":"6","author":"Roland","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.otc.2011.03.010_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1081-1206(10)60355-9","article-title":"Azelastine and olopatadine in the treatment of allergic rhinitis","volume":"103","author":"Kaliner","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.otc.2011.03.010_bib22","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1185\/03007995.2010.485413","article-title":"Olopatadine hydrochloride in children: efficacy and safety for perennial allergic rhinitis","volume":"26","author":"Okubo","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.otc.2011.03.010_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF03258482","article-title":"Evaluation of fluticasone propionate aqueous nasal spray taken alone and in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis","volume":"8","author":"Benincasa","year":"1994","journal-title":"Drug Invest"},{"issue":"2","key":"10.1016\/j.otc.2011.03.010_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2010.06.008","article-title":"Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device","volume":"105","author":"Hampel","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.otc.2011.03.010_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2500\/aap.2010.31.3326","article-title":"Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis","volume":"31","author":"LaForce","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"10","key":"10.1016\/j.otc.2011.03.010_bib26","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1185\/030079907X226302","article-title":"Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability","volume":"23","author":"Bernstein","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.otc.2011.03.010_bib27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1365-2222.2002.01422.x","article-title":"Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring","volume":"32","author":"Philip","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.otc.2011.03.010_bib28","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1046\/j.1398-9995.2003.00261.x","article-title":"Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period","volume":"58","author":"van Adelsberg","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.otc.2011.03.010_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1081-1206(10)61576-1","article-title":"Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies","volume":"92","author":"Chervinsky","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.otc.2011.03.010_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-3038.2005.00351.x","article-title":"Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr","volume":"17","author":"Chen","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.otc.2011.03.010_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1081-1206(10)61018-6","article-title":"Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis","volume":"95","author":"Patel","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.otc.2011.03.010_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1442-200X.2007.02375.x","article-title":"Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis","volume":"49","author":"Hung","year":"2007","journal-title":"Pediatr Int"},{"issue":"5","key":"10.1016\/j.otc.2011.03.010_bib33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.amjmed.2003.10.030","article-title":"Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis","volume":"116","author":"Wilson","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.otc.2011.03.010_bib34","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0149-2918(02)80009-1","article-title":"Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study","volume":"24","author":"Meltzer","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.otc.2011.03.010_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0091-6749(76)90147-0","article-title":"Treatment of perennial allergic rhinitis with cromolyn sodium. Double-blind study on 34 adult patients","volume":"58","author":"Cohan","year":"1976","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.otc.2011.03.010_bib36","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0091-6749(95)70214-8","article-title":"Product characteristics and pharmacokinetics of intranasal ipratropium bromide","volume":"95","author":"Wood","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.otc.2011.03.010_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1081-1206(10)61289-6","article-title":"Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies","volume":"94","author":"Kim","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.otc.2011.03.010_bib38","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0091-6749(95)70217-2","article-title":"Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%","volume":"95","author":"Kaiser","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.otc.2011.03.010_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001831.pub3","article-title":"Over-the-counter medications for acute cough in children and adults in ambulatory settings","volume":"1","author":"Smith","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.otc.2011.03.010_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/ers.09.11","article-title":"Off-label use of omalizumab in non-asthma conditions: new opportunities","volume":"3","author":"Morjaria","year":"2009","journal-title":"Expert Rev Respir Med"},{"issue":"Suppl","key":"10.1016\/j.otc.2011.03.010_bib41","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1164\/ajrccm.164.supplement_1.2103023","article-title":"Anti-IgE (Omalizumab) therapy in seasonal allergic rhinitis","volume":"164","author":"Casale","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.otc.2011.03.010_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1067\/mai.2000.108310","article-title":"Recombinant humanized mAb-E25, an anti IgE mAb, in birch pollen-induced seasonal allergic rhinitis","volume":"106","author":"Adelroth","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.otc.2011.03.010_bib43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1081-1206(10)62171-0","article-title":"Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis","volume":"91","author":"Chervinsky","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.otc.2011.03.010_bib44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1398-9995.2004.00550.x","article-title":"Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR","volume":"59","author":"Vignola","year":"2004","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.otc.2011.03.010_bib45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF03256629","article-title":"Allergens in the pathogenesis of asthma: potential role of anti-immunoglobulin E therapy","volume":"1","author":"Storms","year":"2002","journal-title":"Am J Respir Med"},{"issue":"1 Pt 2","key":"10.1016\/j.otc.2011.03.010_bib46","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1111\/j.1399-3038.2009.00900.x","article-title":"Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously","volume":"21","author":"Kamin","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.otc.2011.03.010_bib47","series-title":"Middleton's allergy: principles and practice","first-page":"1679","article-title":"Anti-IgE therapy","author":"Stokes","year":"2008"},{"issue":"3","key":"10.1016\/j.otc.2011.03.010_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4193\/Rhin09.144","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis","volume":"48","author":"Pinto","year":"2010","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.otc.2011.03.010_bib49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4161\/hv.5.5.7442","article-title":"Vaccines targeting IgE in the treatment of asthma and allergy","volume":"5","author":"Peng","year":"2009","journal-title":"Hum Vaccin"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666511000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666511000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T09:35:46Z","timestamp":1560159346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666511000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0030666511000545"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2011.03.010","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}